Remove 2017 Remove Pharmaceutical manufacturing Remove Safety
article thumbnail

PhRMA lies to protect pharma profits

World of DTC Marketing

Among the 25 worldwide companies that spend the most on research and development—all more than $5 billion a year—seven are pharmaceutical manufacturers, but eight are automobile or automobile parts companies with profit margins under 10 percent. Amazon’s operating margin is under 5 percent.

Pharma 255
article thumbnail

Drug pricing increases are disgraceful

World of DTC Marketing

Among the 25 worldwide companies that spend the most on research and development—all more than $5 billion a year—seven are pharmaceutical manufacturers, but eight are automobile or automobile-parts companies with profit margins under 10 percent. Amazon’s operating margin is under 5 percent.

Insurance 181
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How can the pharma industry address the gap in talent recruitment and development?

pharmaphorum

For instance, in pharmaceutical manufacturing, mistakes in training can lead to contamination or waste, which can cause businesses unnecessary headaches. Lynne Byers, global managing director, Pharmaceuticals and Dietary Supplements Consulting, NSF. She joined NSF in 2017. appeared first on.

article thumbnail

Everything You Need to Know About Market Access in China

PM360

Despite the disruptive impact of the COVID-19 pandemic, steady growth has been evident in China’s pharmaceutical market and research environment. From 2017 to 2022, the Chinese market witnessed a growth rate of 5.3%, compared to the average market growth of 6.6% in the top five European Union markets and 7.1% in the U.S. 2023.1138996.

Marketing 105
article thumbnail

Pharmaceutical Patents: A Challenge for Malaysia

Contrarian Sales Techniques

The paper was presented at the International Conference on Pharmaceutical Research and Development (IPRDC) in Kuala Lumpur, Malaysia, in June 2017. It is noteworthy that Malaysia has a pharmaceutical manufacturing sector that almost exclusively produces generic drugs, with sales revenues amounting to only 1.5%